Published in Neuroimage Clin on September 20, 2013
High-resolution mechanical imaging of glioblastoma by multifrequency magnetic resonance elastography. PLoS One (2014) 0.81
Recent imaging advances in neurology. J Neurol (2015) 0.81
Medial temporal lobe viscoelasticity and relational memory performance. Neuroimage (2016) 0.80
Viscoelasticity of subcortical gray matter structures. Hum Brain Mapp (2016) 0.76
On the characterization of the heterogeneous mechanical response of human brain tissue. Biomech Model Mechanobiol (2016) 0.75
Observation of direction-dependent mechanical properties in the human brain with multi-excitation MR elastography. J Mech Behav Biomed Mater (2016) 0.75
Cerebral multifrequency MR elastography by remote excitation of intracranial shear waves. NMR Biomed (2015) 0.75
Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue. PLoS One (2016) 0.75
Aerobic fitness, hippocampal viscoelasticity, and relational memory performance. Neuroimage (2017) 0.75
Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder. Eur Radiol (2016) 0.75
Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science (1995) 9.66
A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage (2010) 6.24
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology (1992) 6.03
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord (2003) 4.56
Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage (2011) 2.92
A clinical rating scale for progressive supranuclear palsy. Brain (2007) 2.71
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Non-invasive measurement of brain viscoelasticity using magnetic resonance elastography. NMR Biomed (2008) 2.66
Viscoelastic properties of individual glial cells and neurons in the CNS. Proc Natl Acad Sci U S A (2006) 2.64
Magnetic resonance elastography of the brain. Neuroimage (2007) 2.59
In vivo brain viscoelastic properties measured by magnetic resonance elastography. NMR Biomed (2008) 2.48
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol (2009) 2.38
Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology (2000) 2.19
The impact of aging and gender on brain viscoelasticity. Neuroimage (2009) 2.15
Noninvasive assessment of the rheological behavior of human organs using multifrequency MR elastography: a study of brain and liver viscoelasticity. Phys Med Biol (2007) 2.08
Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol (2010) 1.88
MR-elastography reveals degradation of tissue integrity in multiple sclerosis. Neuroimage (2009) 1.83
The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol (2010) 1.80
Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol (2010) 1.79
Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography. J Magn Reson Imaging (2011) 1.72
In vivo viscoelastic properties of the brain in normal pressure hydrocephalus. NMR Biomed (2010) 1.67
MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage (2009) 1.48
Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology (2010) 1.45
Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord (2009) 1.43
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis. PLoS One (2012) 1.41
Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord (2012) 1.38
Viscoelasticity-based MR elastography of skeletal muscle. Phys Med Biol (2010) 1.29
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography. Proc Natl Acad Sci U S A (2012) 1.24
Longitudinal study of callosal microstructure in the normal adult aging brain using quantitative DTI fiber tracking. Dev Neuropsychol (2010) 1.24
Alteration of brain viscoelasticity after shunt treatment in normal pressure hydrocephalus. Neuroradiology (2011) 1.21
Algebraic Helmholtz inversion in planar magnetic resonance elastography. Phys Med Biol (2008) 1.15
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis. Neuroimage Clin (2012) 1.11
Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord (2011) 1.08
Time-harmonic magnetic resonance elastography of the normal feline brain. J Biomech (2010) 1.08
The influence of physiological aging and atrophy on brain viscoelastic properties in humans. PLoS One (2011) 1.08
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathol (2011) 1.06
Multifrequency inversion in magnetic resonance elastography. Phys Med Biol (2012) 1.04
Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis (2010) 1.02
Transmission, attenuation and reflection of shear waves in the human brain. J R Soc Interface (2012) 0.98
Subzone based magnetic resonance elastography using a Rayleigh damped material model. Med Phys (2011) 0.95
An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr Opin Neurol (2005) 0.94
Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol (2005) 0.94
MR elastography in a murine stroke model reveals correlation of macroscopic viscoelastic properties of the brain with neuronal density. NMR Biomed (2013) 0.90
Fractal network dimension and viscoelastic powerlaw behavior: II. An experimental study of structure-mimicking phantoms by magnetic resonance elastography. Phys Med Biol (2012) 0.89
Fractal network dimension and viscoelastic powerlaw behavior: I. A modeling approach based on a coarse-graining procedure combined with shear oscillatory rheometry. Phys Med Biol (2012) 0.85
Travelling wave expansion: a model fitting approach to the inverse problem of elasticity reconstruction. IEEE Trans Med Imaging (2011) 0.81
Spatial patterns of the tau pathology in progressive supranuclear palsy. Neurol Sci (2012) 0.79
Fractal ladder models and power law wave equations. J Acoust Soc Am (2009) 0.76
No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol (2010) 4.31
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum (2005) 4.12
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet (2013) 3.83
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2006) 3.51
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. Ann Rheum Dis (2013) 3.43
Photoreceptor layer thinning in idiopathic Parkinson's disease. Mov Disord (2014) 3.36
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int (2002) 2.95
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum (2008) 2.75
Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum (2006) 2.67
Non-invasive measurement of brain viscoelasticity using magnetic resonance elastography. NMR Biomed (2008) 2.66
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis (2011) 2.61
Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol (2014) 2.52
Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum (2008) 2.48
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum (2009) 2.45
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol (2008) 2.40
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis (2010) 2.34
The impact of aging and gender on brain viscoelasticity. Neuroimage (2009) 2.15
The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns. Arthritis Rheumatol (2014) 2.14
Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum (2008) 2.14
Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol (2012) 2.12
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis (2012) 2.10
Noninvasive assessment of the rheological behavior of human organs using multifrequency MR elastography: a study of brain and liver viscoelasticity. Phys Med Biol (2007) 2.08
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum (2008) 2.04
A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol (2013) 1.99
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis (2011) 1.90
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med (2015) 1.83
MR-elastography reveals degradation of tissue integrity in multiple sclerosis. Neuroimage (2009) 1.83
Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med (2008) 1.80
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Arthritis Rheum (2003) 1.79
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis (2013) 1.74
Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis. Br J Ophthalmol (2011) 1.73
Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol (2013) 1.69
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology (2012) 1.67
In vivo viscoelastic properties of the brain in normal pressure hydrocephalus. NMR Biomed (2010) 1.67
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum (2012) 1.66
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation (2010) 1.60
Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol (2006) 1.57
Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment. Neurology (2009) 1.53
T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients. Neurology (2013) 1.51
Fractional encoding of harmonic motions in MR elastography. Magn Reson Med (2007) 1.49
MR elastography of the human heart: noninvasive assessment of myocardial elasticity changes by shear wave amplitude variations. Magn Reson Med (2009) 1.47
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci (2010) 1.45
Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology (2010) 1.45
Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis (2010) 1.43
Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2013) 1.42
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis. PLoS One (2012) 1.41
Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med (2004) 1.41
In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography. Invest Radiol (2006) 1.35
Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health. J Rheumatol (2006) 1.35
Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis (2011) 1.35
Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (Hoboken) (2012) 1.34
Perivascular spaces--MRI marker of inflammatory activity in the brain? Brain (2008) 1.33
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis (2011) 1.33
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol (2009) 1.32
Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg (2010) 1.30
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler (2013) 1.30
Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis (2012) 1.30
Shear wave group velocity inversion in MR elastography of human skeletal muscle. Magn Reson Med (2006) 1.29
Viscoelasticity-based MR elastography of skeletal muscle. Phys Med Biol (2010) 1.29
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis (2013) 1.29
ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis. Arthritis Rheum (2005) 1.28
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One (2010) 1.25
Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int (2012) 1.24
In vivo waveguide elastography of white matter tracts in the human brain. Magn Reson Med (2012) 1.23
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler (2012) 1.23
Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab. J Rheumatol (2002) 1.21
Alteration of brain viscoelasticity after shunt treatment in normal pressure hydrocephalus. Neuroradiology (2011) 1.21
A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Ann Rheum Dis (2010) 1.20
First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology (Oxford) (2012) 1.19
What went wrong? The flawed concept of cerebrospinal venous insufficiency. J Cereb Blood Flow Metab (2013) 1.19
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler (2011) 1.19
Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler (2012) 1.18
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis. PLoS One (2013) 1.18
Cardiac magnetic resonance elastography. Initial results. Invest Radiol (2008) 1.17
Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex. Brain (2011) 1.17
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler (2013) 1.16
Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study. Arch Neurol (2012) 1.16
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Rheum (2006) 1.15
Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS One (2011) 1.14
Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One (2013) 1.13